Campath

Product manufactured by Genzyme Corporation

Application Nr Approved Date Route Status External Links
BLA103948 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Campath Is Indicated As A Single Agent For The Treatment Of B-Cell Chronic Lymphocytic Leukemia (B-Cll). Campath Is A Cd52-Directed Cytolytic Antibody Indicated As A Single Agent For The Treatment Of B-Cell Chronic Lymphocytic Leukemia (B-Cll). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alemtuzumab

Comments